Supporting women in their contraceptive choices

Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill

New pharmacy category

8-minute module

Supporting women
in their contraceptive choices

Desogestrel 75 micrograms film-coated tablets, under the brand name Lovima, have been reclassified as a Pharmacy-only (P) medicine for use as a daily hormonal contraceptive in women of child-bearing age, to be supplied under the supervision of a pharmacist. Lovima is a type of progesterone-only pill (POP).

Objectives

To support you in conducting effective, patient-specific consultations on contraception and enable you to appropriately supply Lovima 75 micrograms film-coated tablets (desogestrel), which is now available from pharmacies without a prescription for women who are eligible.

Active pack

The Lovima carton is designed to act as a tool (an 'active pack') to give you the prompts you need to aid the consultation process.

Click the hotspots around the active pack to find out some of the key information about Lovima. It is important that you read the full training and consultation resources. You can download these at the end of this module.

 

Active ingredient: Desogestrel 75 micrograms

Proceed to the next screen to continue the module, where you will find FAQs, more detail on contraceptive options and customer scenarios.

Product Information

LOVIMA® 75 MICROGRAM FILM-COATED TABLETS (DESOGESTREL) - PL 42807/0002
Indications: Oral contraception for women of childbearing age including adolescents. Posology: One tablet every day continuously; 24 hours between tablets. First tablet taken on the first day of menstrual bleeding. Contraindications: Active venous thromboembolic disorder. Presence or history of severe hepatic disease. Known or suspected sex-steroid sensitive malignancies. Undiagnosed vaginal bleeding. Hypersensitivity to any ingredients. Peanut or soya allergy. Precautions: Pregnancy should be excluded. Contains lactose. Not for patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption. Caution in patients with: a history of breast cancer, diabetes, liver cancer or chloasma or depressed mood arising during use. Efficacy may be reduced with missed tablets, gastro-intestinal disturbances, or concomitant medications. Stop if sustained hypertension not controlled. Side effects: Common (≥1/100 to <1/10) breast pain; depressed mood; mood altered; libido decreased; menstrual cycle irregularities; nausea; acne; weight increased, headache. Uncommon (≥1/1,000 to <1/100) vaginal infections; contact lens intolerance; vomiting; alopecia; dysmenorrhoea; ovarian cyst; fatigue. Rare (≥1/10,000 to <1/1,000) rash, urticaria, erythema nodosum. MA holder: Maxwellia Ltd, Alderley Park, Alderley Edge, SK10 4TG Classification: P Price (ex.VAT): 28 tablets £14.28, 84 tablets £28.56. Date: July 2021.

Lovima is a registered trade mark of Maxwellia Ltd. Content developed by Maxwellia working together with CIG Healthcare Partnership.
© 2021 CIG Healthcare Partnership.
Date of preparation: December 2020

Share:

More like this

bookmark_icon_off
Sponsored education

Abdominal discomfort: Multi-symptom relief with Buscomint

Discover the key benefits of a product that offers multi-symptom relief from abdominal pain, cramps and bloating, plus lifestyle advice to help manage symptoms.

5 Min Module

bookmark_icon_off
Sponsored education

Managing hay fever: help meet your customers' needs

This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the right products to ease symptoms

15 Min Module

Sponsored education

A new approach to osteoarthritis and joint pain

When customers come to your pharmacy with joint pain associated with osteoarthritis or joint wear and tear, it may mean they have reached the point where their quality of life is being impacted.

18 Min Module

bookmark_icon_off
Sponsored education

Confident pet health conversations

Learn 3 key steps to having more confident conversations with customers about pet health products.

3 Min Module

bookmark_icon_off
Sponsored education

Oral rehydration: a pharmacy guide

Understand the important role oral rehydration products play in helping prevent dehydration after illness

5 Min Module

Sponsored education

Challenging your thinking about oral pain relief

This short module contains three videos that review evidence about OTC pain relief, to challenge your thinking when recommending products.

15 Min Module

Recommended Learning

bookmark icon off
Sponsored education

Indigestion update

Update your knowledge on indigestion with this short video and discover a new dual-action product you can recommend.

3 Min Module

bookmark icon off
Sponsored education

Confident pet health conversations

Learn 3 key steps to having more confident conversations with customers about pet health products.

3 Min Module

Sponsored education

Supporting women in their contraceptive choices

Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill

8 Min Module

bookmark icon off
Sponsored education

OTC Omeprazole tablets 20mg: an opportunity for pharmacy

This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.

10 Min Module

bookmark icon off
Sponsored education

Understanding abdominal pain, cramps and IBS

This short video explains the symptoms of irritable bowel syndrome (IBS) and how it differs from abdominal cramps to help you recommend a suitable product for your customer’s needs.

3 Min Module

bookmark icon off
Sponsored education

Managing fever in children

Get to grips with the current guidance on managing fever in children and how antipyretics can help, and discover products you can recommend.

10 Min Module